About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 34078190 Journal: SCIENCE PROGRESS Year: 2021 Reference: Sci Prog. 2021 Apr-Jun;104(2):368504211018580. doi: 10.1177/00368504211018580. Impact factor: 2.774 Publication type: Paper in international publication Authors: Tomasa-Irriguible, Teresa M, Sabater-Riera, Joan, Perez-Carrasco, Marcos, Ortiz-Ballujera, Patricia, Diaz-Buendia, Yolanda, Navas-Perez, Ana, Betbese-Roig, Antoni, Rodriguez-Lopez, Miguel, Ibarz-Vilamayor, Mercedes, Olmo-Isasmendi, Aitor et al. DOI: 10.1177/00368504211018580
PMID: 34078421 Journal: Trials Year: 2021 Reference: Trials. 2021 Jun 2;22(1):376. doi: 10.1186/s13063-021-05311-8. Impact factor: 2.279 Publication type: Paper in international publication Authors: Zacharowski, Kai, Ichai, Carole, Asehnoune, Karim, Cerny, Vladimir, Dembinski, Rolf, Ferrer Roca, Ricard, Fries, Dietmar, Molnar, Zsolt, Rosenberger, Peter, Sanchez-Sanchez, Manuel et al. DOI: 10.1186/s13063-021-05311-8
PMID: 34082060 Journal: JOURNAL OF HOSPITAL INFECTION Year: 2021 Reference: J Hosp Infect. 2021 Oct;116:103-105. doi: 10.1016/j.jhin.2021.04.034. Epub 2021 May 31. Impact factor: 3.926 Publication type: Letter or abstract Authors: Armadans, Lluis, Segales, Joaquim, Pumarola, Tomas, Campins, Magda, Ferrer, Ricard, Rodriguez-Garrido, Virginia, Vergara-Alert, Julia, Anton, Andres, Rodon, Jordi, Pacheco, Andres et al. DOI: 10.1016/j.jhin.2021.04.034
PMID: 34037963 Journal: DRUGS Year: 2021 Reference: Drugs. 2021 Jun;81(9):1065-1078. doi: 10.1007/s40265-021-01534-w. Epub 2021 May 26. Impact factor: 9.546 Publication type: Review in international publication Authors: Vogelaers, Dirk, Blot, Stijn, Van den Berge, Andries, Montravers, Philippe, Francois, Guy, Labeau, Sonia, Blot, Koen, Deschepper, Mieke, Antonelli, Massimo, Lipman, Jeffrey et al. DOI: 10.1007/s40265-021-01534-w
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
